These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19886587)

  • 1. Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
    Kaliebe JW; Murdock DK
    WMJ; 2009 Oct; 108(7):373-5. PubMed ID: 19886587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
    Murdock DK; Kaliebe J; Overton N
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):765-8. PubMed ID: 18507552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
    Nanda S; Levin V; Martinez MW; Freudenberger R
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):e119-20. PubMed ID: 20345626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine for the suppression of ventricular arrhythmia: a case series.
    Yeung E; Krantz MJ; Schuller JL; Dale RA; Haigney MC
    Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):345-50. PubMed ID: 24533675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic properties of ranolazine--from bench to bedside.
    Tzeis S; Andrikopoulos G
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine for the management of coronary artery disease.
    Cheng JW
    Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".
    Ayalloore SG; LeLorier P
    Circulation; 2011 Apr; 123(14):e404; author reply e405. PubMed ID: 21482971
    [No Abstract]   [Full Text] [Related]  

  • 10. The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel.
    Kloner RA; Dow JS; Bhandari A
    Cardiovasc Ther; 2011 Aug; 29(4):e36-41. PubMed ID: 20626400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
    Scirica BM; Braunwald E; Belardinelli L; Hedgepeth CM; Spinar J; Wang W; Qin J; Karwatowska-Prokopczuk E; Verheugt FW; Morrow DA
    Circulation; 2010 Aug; 122(5):455-62. PubMed ID: 20644019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine. A metabolic modulator for the treatment of chronic stable angina.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2005; 13(4):202-10. PubMed ID: 15949056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ranolazine in a patient with idiopathic dilated cardiomyopathy and electrical storm.
    Vizzardi E; D'Aloia A; Salghetti F; Aljassim O; Raweh A; Bonadei I; Bontempi L; Curnis A
    Drug Discov Ther; 2013 Feb; 7(1):43-5. PubMed ID: 23524943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ranolazine--an additional anti-anginal drug].
    Michels G; Kochanek M; Hoppe UC
    Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Madias regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".
    Madias JE
    Circulation; 2011 Apr; 123(14):e403; author reply e405. PubMed ID: 21482970
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
    Sossalla S; Maier LS
    Pharmacol Ther; 2012 Mar; 133(3):311-23. PubMed ID: 22133843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
    Nieminen T; Scirica BM; Pegler JR; Tavares C; Pagotto VP; Kanas AF; Sobrado MF; Nearing BD; Umez-Eronini AA; Morrow DA; Belardinelli L; Verrier RL
    Am J Cardiol; 2014 Jul; 114(1):17-23. PubMed ID: 24852915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution?
    Patton KK
    Circulation; 2010 Aug; 122(5):449-51. PubMed ID: 20644012
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of frequent ventricular ectopy in a patient with hypertrophic heart disease with ranolazine: a case report.
    Murdock DK; Kaliebe JW
    Indian Pacing Electrophysiol J; 2011 May; 11(3):84-8. PubMed ID: 21556158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
    Stone PH
    Cardiol Clin; 2008 Nov; 26(4):603-14. PubMed ID: 18929234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.